These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25123453)

  • 21. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation.
    Han ZB; Chen HY; Fan JW; Wu JY; Tang HM; Peng ZH
    J Cancer Res Clin Oncol; 2012 Jan; 138(1):153-61. PubMed ID: 22071603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
    Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
    Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q; Cai W; Zhang M; Liu Q; Liu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating miR-130b- and miR-21-based diagnostic markers and therapeutic targets for hepatocellular carcinoma.
    Zhang N; Hu Z; Qiang Y; Zhu X
    Mol Genet Genomic Med; 2019 Dec; 7(12):e1012. PubMed ID: 31660696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
    Yu L; Zhang J; Guo X; Li Z; Zhang P
    Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Wang X; Huang Y; Zhuang H; Qian Y; Zhao Q; Yang L; Gu H; Chen J; Guo R; Liu Y
    Clin Lab; 2015; 61(9):1331-6. PubMed ID: 26554254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of miR-454 overexpression in the poor prognosis of hepatocellular carcinoma.
    Zhou L; Qu YM; Zhao XM; Yue ZD
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):825-9. PubMed ID: 27010136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of miR-522 is associated with poor outcome of hepatocellular carcinoma.
    Shi YH; Qi BB; Liu XB; Ding HM
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(15):3194-8. PubMed ID: 27466991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma.
    Liang H; Ai-Jun J; Ji-Zong Z; Jian-Bo H; Liang Z; Yong-Xiang Y; Chen Y
    Anticancer Drugs; 2019 Feb; 30(2):186-194. PubMed ID: 30418194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3.
    Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W
    Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease.
    Hung CL; Yen CS; Tsai HW; Su YC; Yen CJ
    BMC Cancer; 2015 Oct; 15():665. PubMed ID: 26453548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
    Li B; Shao Q; Ji D; Li F; Guo X; Chen G
    Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma.
    Fu C; Xu X; Lu W; Nie L; Yin T; Wu D
    Medicine (Baltimore); 2019 Oct; 98(42):e17412. PubMed ID: 31626095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of miR-3607 predicts prognosis of hepatocellular carcinoma and regulates tumor cell proliferation, migration and invasion.
    Dou W; Yang M; Su Y; Xie R
    Diagn Pathol; 2020 May; 15(1):54. PubMed ID: 32404179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
    Chen P; Zhao X; Ma L
    Mol Cell Biochem; 2013 Nov; 383(1-2):49-58. PubMed ID: 23842624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma.
    Tu K; Zheng X; Dou C; Li C; Yang W; Yao Y; Liu Q
    Int J Mol Sci; 2014 Nov; 15(11):20486-99. PubMed ID: 25387077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
    Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
    Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
    Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
    Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.